Immunotherapy and Modern Radiotherapy Technique for Older Patients with Locally Advanced Head and Neck Cancer: A Proposed Paradigm by the International Geriatric Radiotherapy Group

SIMPLE SUMMARY: Immunotherapy with checkpoint inhibitors (CPI) is well tolerated in older cancer patients due to its safety profile. In selected patients with a high program death-ligand 1 (PD-L1) tumor expression defined as 50% or above, the response rate and survival are significantly better than...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Nam P., Kim, Lyndon, Thariat, Juliette, Baumert, Brigitta G., Mazibuko, Thandeka, Gorobets, Olena, Vinh-Hung, Vincent, Giap, Huan, Mehmood, Tahir, Vincent, Felix, Chi, Alexander, Basu, Trinanjan, Loganadane, Gokoulakrichenane, Mohammadianpanah, Mohammad, Karlsson, Ulf, Oboite, Eromosele, Oboite, Joan, Ali, Ahmed, Page, Brandi R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654379/
https://www.ncbi.nlm.nih.gov/pubmed/36358703
http://dx.doi.org/10.3390/cancers14215285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654379/
https://www.ncbi.nlm.nih.gov/pubmed/36358703
http://dx.doi.org/10.3390/cancers14215285

Ejemplares similares